Claims
- 1. A compound, or a salt thereof, of formula: ##STR13## wherein X.sup.1 and X.sup.2 are independently chosen from chlorine and fluorine.
- 2. A pharmaceutical composition comprising a compound, or a salt thereof, of formula: ##STR14## wherein X.sup.1 and X.sup.2 are independently chosen from chlorine and fluorine and a pharmaceutically acceptable carrier.
- 3. A method for treating fungal infection comprising administering to a mammal suffering from said fungal infection a therapeutically effective amount of a compound, or salt thereof, of formula: ##STR15## wherein X.sup.1 and X.sup.2 are independently chosen from chlorine and fluorine.
- 4. A method according to claim 3 wherein said fungal infection is central candidiasis.
Parent Case Info
This is a continuation of Ser. No. 08/968,780 filed Nov. 12, 1997 U.S. Pat. No. 5,952,502 and claims priority of Provisional appl. Ser. No. 60/029,990 filed Nov. 12, 1996.
US Referenced Citations (17)
Foreign Referenced Citations (3)
Number |
Date |
Country |
WO 9319061 |
Sep 1993 |
WOX |
WO 9517407 |
Jun 1995 |
WOX |
WO 9519983 |
Jul 1995 |
WOX |
Non-Patent Literature Citations (1)
Entry |
Saksena et al., "Concise Asymmetric Routes to 2,2,4-Trisubstituted Tetrahydrofurans Via Chiral Titanium Imide Enolates: Key Intermediates Towards Synthesis of Highly Active Azole Antifungals SCH 51048 and SCH 56592", Tetrahedron Letters, 37, No. 32, 5657-5660, 1996. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
968780 |
Nov 1997 |
|